Healthcare -
Biotechnology - NASDAQ - US
$ 9.97
-0.103 %
$ 460 M
Market Cap
-3.26
P/E
URGN - CASH FROM OPERATIONS
Cash from Operations URGN - UroGen Pharma Ltd.
-96.8 M
LAST VALUE
-5.13%
2 YEAR CAGR
-6.38%
5 YEAR CAGR
-37.12%
10 YEAR CAGR